Doxorubicin HCl
About Haorui
Products
Technology
Contact
Doxorubicin HCl clinical trial-2
61
Active, not recruiting
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
Conditions:
Liver Cancer; Metastatic Cancer
Interventions:
Drug: lyso-thermosensitive liposome doxorubicin; Procedure: radiofrequency ablation
62
Terminated
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
Condition:
Pancreatic Cancer
Intervention:
Drug: Avastin, Fluorouracil, Doxorubicin, Streptozocin
63
Recruiting
Phase II R-ABVD Versus ABVD for Advanced Stage Classical Hodgkin Lymphoma
Condition:
Hodgkin Lymphoma
Interventions:
Drug: Rituximab; Drug: Adriamycin; Drug: Bleomycin; Drug: Vinblastine; Drug: Dacarbazine
64
Active, not recruiting
The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (Study P04445AM2)
Condition:
Breast Cancer
Interventions:
Drug: Pegylated liposomal doxorubicin (SCH 66336); Drug: Capecitabine
65
Recruiting
Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
Condition:
Ovarian Cancer
Interventions:
Drug: Docetaxel; Drug: Carboplatin; Drug: Liposomal doxorubicin
66
Active, not recruiting
Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin
Condition:
Cancer
Intervention:
Drug: Nexavar (Sorafenib, BAY43-9006)
67
Recruiting
Efficacy and Safety and Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer
Condition:
Ovarian Cancer
Interventions:
Drug: Doxil; Drug: Bevacizumab (Avastin)
68
Recruiting
Liposomal Doxorubicin and Docetaxel in Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer
Conditions:
Breast Cancer; Neoplasm Metastasis
Intervention:
Drug: Non pegylated liposomal doxorubicin and docetaxel
69
Completed
A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
Conditions:
Sarcoma, Kaposi; HIV Infections
Intervention:
Drug: Doxorubicin hydrochloride (liposomal)
70
Completed
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
Condition:
Glioblastoma
Intervention:
Drug: Pegylated Liposomal Doxorubicine
71
Suspended
Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer
Condition:
Metastatic Breast Cancer
Intervention:
Drug: PS-341, doxorubicin
72
Active, not recruiting
Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
Condition:
Breast Cancer
Intervention:
Drug: Doxorubicin, Cyclophosphamide, Paclitaxel, Sorafenib
73
Active, not recruiting
Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition:
Breast Cancer
Interventions:
Drug: cyclophosphamide; Drug: methotrexate; Drug: pegylated liposomal doxorubicin hydrochloride; Procedure: adjuvant therapy; Radiation: radiation therapy
74
Active, not recruiting
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
Condition:
Liver Cancer
Interventions:
Drug: doxorubicin hydrochloride; Procedure: hepatic artery embolization
75
Recruiting
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Condition:
Sarcoma
Interventions:
Biological: pegfilgrastim; Drug: doxorubicin hydrochloride; Drug: ifosfamide; Procedure: multimodality therapy
76
Terminated
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
Condition:
Pancreatic Cancer
Interventions:
Drug: Docetaxel; Drug: Liposomal Doxorubicin; Drug: Enoxaparin
77
Recruiting
A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer
Condition:
Endometrial Cancer
Interventions:
Drug: Ixabepilone; Drug: Doxorubicin; Drug: Paclitaxel
78
Completed
A Study of Docetaxel Monotherapy or DOXIL/CAELYX and Docetaxel in Patients With Advanced Breast Cancer
Condition:
Cancer of Breast
Interventions:
Drug: Docetaxel; Drug: DOXIL in combination with Docataxel
79
Recruiting
Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
Condition:
Prostate Cancer
Interventions:
Drug: Taxotere; Drug: Doxil
80
Active, not recruiting
Docetaxel in Breast Cancer
Condition:
Breast Cancer
Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved